Home/ Supplements/ Electrolytes/ High Potency Serrapeptase 120,000 SPU

High Potency Serrapeptase 120,000 SPU

product on market Capsule Doctor's Best Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for High Potency Serrapeptase 120,000 SPU
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
35 mg (3% DV)
Serrapeptase

Other Ingredients

Maltodextrin Tricalcium Phosphate Calcium Stearate Microcrystalline Cellulose Medium Chain Triglyceride Hypromellose Gellan Gum Water, Purified
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested adult use: Take 1 capsule daily with at least 8 oz. of water on an empty stomach, or as recommended by a nutritionally informed physician. First time users may benefit from starting with lower dosage Serrapeptase 40,000 SPU.

Warnings & Precautions

Warning: Not recommended if you are pregnant, nursing, taking blood thinners, or have poor digestion.

Stop taking if you experience nausea, vomiting, or stomach upset.

Keep out of reach of children

Formulation Notes

Serrapeptase (serratio-peptidase) is a protein-digesting enzyme isolated from the friendly bacterium Serratia E-15 discovered in the Japanese silkworm, and has been used as a nutritional supplement in Europe and Asia for over three decades. Doctor's Best Serrapeptase 120,000 SPU is formulated with Serrateric, a superior alternative to enteric coating that protects the individual enzyme until it reaches the intestine for optimal absorption.

Helps support healthy sinuses Helps breakdown unwanted proteins

Vegan

Additional Information

Facebook Instagram Twitter

SPU - serratiopeptidase activity units

Metadata

Product Details

UPC / SKU7 53950 00307 1
DSLD Entry Date2024-01-24
Product TypeOther Combinations
FormCapsule
DSLD ID302679
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.